| Autor: |
Grangeon, A., Mallet, S., Miquel, J., Passeron, T., Delaporte, E., Bellissen, A. |
| Předmět: |
|
| Zdroj: |
Journal of the European Academy of Dermatology & Venereology; Mar2024, Vol. 38 Issue 3, pe254-e255, 2p |
| Abstrakt: |
This article discusses a case of lentigines, or small hyperpigmented macules, that appeared on the wrists, hands, and knees of an 8-year-old girl with a history of atopic dermatitis. The lentigines developed after the patient started treatment with dupilumab, a medication used to treat atopic dermatitis. The article suggests that the inhibition of the IL-4 and IL-13 pathway by dupilumab may lead to an unregulated upregulation of melanogenesis, resulting in the formation of lentigines. The article emphasizes that lentigines are a rare and benign adverse event and reassures patients that they are not associated with an increased risk of skin cancer. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text